Immunotherapy in combination with chemotherapy, first line treatment in patients with metastatic triple negative breast cancer

Javier Cortes H. Ruber international

The research led by Dr. Javier Cortés, head of the Breast Cancer Program at Hospital Ruber Internacional, reveals that adding pembrolizumab, a type of immunotherapy to chemotherapy before surgery, significantly increases the chances that the tumor will not reappear